Stroke survivors get FDA-approved daily pill shown to cut repeat risk by 26%

How 1 sources are covering this

• Fox NewsRight·1h ago

  Stroke survivors get FDA-approved daily pill shown to cut repeat risk by 26%

  Sunharbo (asundexian) is the first FDA-approved factor XIa inhibitor for secondary stroke prevention, but key limitations and risks do remain.

  Read at Fox News →